Lamotrix

Lamotrigine, the active ingredient in Lamotrix, is a Anticonvulsant presented as an oral tablet for Oral use. It is used to treat epilepsy and bipolar disorder in both adult and pediatric patients.

GNH USA supplies Lamotrix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is an anticonvulsant that acts on neuronal excitability in several neurological and psychiatric conditions.

Epilepsy: reduces the frequency and severity of seizures. Bipolar disorder: stabilises mood and decreases the occurrence of manic episodes.

Lamotrigine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: transient feeling of light‑headedness. - Headache: mild to moderate intensity. - Nausea: occasional upset stomach. - Rash: skin irritation that may appear as redness or itching. - Fatigue: general tiredness or lack of energy. - Tremor: slight shaking of hands or limbs.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction requiring immediate medical attention. - Aseptic meningitis: inflammation of the meninges presenting with headache and fever. - Blood dyscrasias: abnormal blood counts such as leukopenia. - Hepatic dysfunction: elevated liver enzymes indicating liver stress. - Severe hypersensitivity: widespread rash, fever, and organ involvement. - Suicidal ideation: emergence of thoughts of self‑harm.

Before using Lamotrix, consider the following safety measures.

Allergy assessment: confirm no known hypersensitivity to lamotrigine or its excipients. Pregnancy counseling: discuss potential risks with a healthcare professional. Renal/hepatic function: dose may need adjustment in impaired patients. Concomitant medications: review other drugs for possible interactions. Monitoring: regular clinical and laboratory checks are advised. Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Lamotrigine can interact with several medicines, influencing its effectiveness or safety.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine plasma levels. - Carbamazepine: reduces lamotrigine concentrations, risking loss of efficacy. - Phenobarbital: lowers lamotrigine levels, potentially causing breakthrough seizures.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may decrease lamotrigine levels, requiring dose review. - Serotonergic agents: combined use may increase risk of serotonin syndrome. - Other antiepileptics: may alter lamotrigine metabolism, necessitating monitoring.